About Serán BioScience
Serán BioScience is a Healthcare company based in Bend (United States) founded in 2016 by Dan Smithey, and was acquired by Vivo Capital in January 2021. It operates as a provider of drug development, manufacturing and regulatory services. Its chief executive is Dan Smithey. Serán BioScience offers products and services including Preformulation Services, Formulation Development, Dosage Form Development, Spray Drying and Particle Engineering, and cGMP Manufacturing. Its focus areas include Biopharma Outsourcing, Diversified and Small Molecules & Peptides. Its legal entity is Serán Bioscience, LLC. Its competitors include Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
Serán BioScience, founded in 2016 in Bend, United States, focuses on providing healthcare solutions, biopharma outsourcing, diversified, and small molecules peptides. Provider of drug development, manufacturing and regulatory services. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Bend, United States
- Founders Dan Smithey
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website seranbio.com
- Social LinkedIn X Facebook
- Acquired by Vivo Capital (Jan 2021)
- Legal Name Serán Bioscience, Llc
- InvestorsBain Capital Life Sciences
& 1 more
- Acquired byVivo Capital
(Jan 2021)
Products & Services of Serán BioScience
Serán BioScience offers a comprehensive portfolio of products and services, including Preformulation Services, Formulation Development, Dosage Form Development, Spray Drying and Particle Engineering, and cGMP Manufacturing.
Early analysis and optimization of drug properties for formulation.
Design and testing of stable drug formulations for efficacy.
Creation of various dosage forms for clinical applications.
Engineering particles to improve drug delivery and stability.
Production of drugs under cGMP standards for clinical use.
Funding Insights of Serán BioScience
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Serán BioScience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | – | Seed | – | Bain Capital Life Sciences | – |
2 investors in total: 2 institutional.
Investors in Serán BioScience
Serán BioScience has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Bain Capital Life Sciences and Vivo Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are focused on pharmaceutical, biotechnology, and medical sectors. | – | baincapitallifesciences.com | Boston, United States | |
Venture capital and private equity firm | – | vivocapital.com | Palo Alto, United States |
Investor details for Serán BioScience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Serán BioScience
60 people are tracked at Serán BioScience (17 in leadership, 43 in team).
| Name | Role | Group |
|---|---|---|
Dan Smithey | Founder & CEO | Leadership |
Anthony Georger | Vice President Finance & Accounting | Leadership |
Brian Boucher | Associate Director of Operations | Leadership |
James “Trey” Gray III | Associate Director of Operations | Leadership |
Ross W. Lundman | Director of Manufacturing Operations | Leadership |
Laura Wilke | Senior Director, Project Management | Leadership |
Randy Wald | Drug Product Fellow and VP | Leadership |
Rod Ketner | Vice President, Business Operations | Leadership |
SeránBio IT | Director of IT | Leadership |
Dan Smithey, PhD | President, CEO and Founder | Leadership |
Blake Cerruti | Associate Director Of Supply Chain | Leadership |
Heather Hansen | VP Corporate And Legal And General Counsel | Leadership |
Justin Barrett | Director of Analytical Sciences | Leadership |
Mandy Cameron, M.S. | Senior Director of Quality Assurance | Leadership |
Max Herbig | Director of Facilities Engineering | Leadership |
Mark Kastantin | VP Manufacturing Technology | Leadership |
Erica Schlesinger | VP Technical Development | Leadership |
Shannon Scoglio | Project Management Coordinator | Team |
Matthew Wood | Operations Specialist II | Team |
Michael Biermann | Project Manager | Team |
40 more people are available in the full profile.
Complete people profiles for Serán BioScience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Serán BioScience
3 dated milestones of Serán BioScience across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Serán BioScience is founded.
- Exit Acquired by Vivo Capital.
- Funding First funding round.
Competitors of Serán BioScience
Serán BioScience has 9 listed competitors in our database, 7 of them funded. They include Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pharmaron.com | 2003 | Beijing, China | $320M | 476 | Drug discovery and development services for small molecules are provided. | |
| pfizer.com | 1849 | New York, United States | $8M | – | Pharmaceutical products for treating multiple diseases are provided. | |
| boehringer-ingelheim.com | 1885 | – | – | 31 | Generic drugs and clinical research services are provided globally. | |
| lonza.com | 1897 | Basel, Switzerland | $100,000 | 14,500 | CDMO services for pharma, biotech, and specialty ingredients are provided. | |
| dotmatics.com | 2005 | – | $11.34M | 512 | AI powered scientific data management and workflow automation solutions | |
| labconnect.com | 2002 | Johnson, United States | $28.5M | – | Laboratory testing, clinical trial research, and biopharma services are provided. | |
| lindushealth.com | 2021 | London, United Kingdom | $78M | 7 | Contract-based clinical trials and recruitment services are provided. | |
| matchpointtx.com | 2021 | Cambridge, United States | $100M | 27 | Small molecule medicine development and analytics services are provided. | |
| ainos.com | 1986 | San Diego, United States | – | 43 | Novel point-of-care testing and low-dose interferon therapeutics are developed. |
Detailed competitors of Serán BioScience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Serán BioScience
The website of Serán BioScience (seranbio.com) receives about 4.7K visits a month.
- Monthly visits4.7K
▲ 23.5% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Serán BioScience (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Serán Bioscience
Complete news archive for Serán BioScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Serán BioScience
Serán BioScience was founded in 2016 and raised its 1st funding round 8 years after it was founded.
Serán BioScience is headquartered in Bend, United States. It is registered at Bend, Oregon, United States.
Dan Smithey is the current CEO of Serán BioScience. They have also founded this company.
Serán BioScience, founded in 2016 in Bend, United States, focuses on providing healthcare solutions, biopharma outsourcing, diversified, and small molecules peptides. Provider of drug development, manufacturing and regulatory services. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Serán BioScience offers Preformulation Services, Formulation Development, Dosage Form Development, Spray Drying and Particle Engineering, and cGMP Manufacturing.
Serán BioScience has 2 investors. Key investors include Bain Capital Life Sciences, and Vivo Capital.
Serán BioScience operates through Serán Bioscience, Llc.
Yes. Serán BioScience was acquired by Vivo Capital in January 2021.